For: | Axiaris G, Zampeli E, Michopoulos S, Bamias G. Management of hepatitis B virus infection in patients with inflammatory bowel disease under immunosuppressive treatment. World J Gastroenterol 2021; 27(25): 3762-3779 [PMID: 34321842 DOI: 10.3748/wjg.v27.i25.3762] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v27/i25/3762.htm |
Number | Citing Articles |
1 |
Seung Hwan Shin, Sang Hyoung Park. Viral Hepatitis in Patients with Inflammatory Bowel Disease. The Korean Journal of Gastroenterology 2022; 80(2): 51 doi: 10.4166/kjg.2022.096
|
2 |
Sara Fernández Sánchez-Escalonilla, Jesus Gonzalez-Rubio, Alberto Najera, Jose Miguel Cantero Escribano, Francisco Jesús Molina Cabrero, Jesús García Guerrero. Using the AS04C-adjuvanted hepatitis B vaccine in patients classified as non-responders. Transactions of The Royal Society of Tropical Medicine and Hygiene 2024; 118(3): 170 doi: 10.1093/trstmh/trad078
|
3 |
Mohammad Shehab, Fatema Alrashed, Munerah Alyaseen, Zainab Safar, Tunrayo Adekunle, Ahmad Alfadhli, Talat Bessissow. Immunogenicity of Hepatitis B Vaccination in Patients with Ulcerative Colitis on Infliximab Is Attenuated Compared to Those on 5-Aminosalicylic Acid Therapies: A Prospective Observational Study. Vaccines 2024; 12(4): 364 doi: 10.3390/vaccines12040364
|
4 |
Juliette Besombes, Faouzi Souala, Guillaume Bouguen, Dominique Guyader, Claire Grolhier, Vincent Thibault, Charlotte Pronier. Acute hepatitis B virus infection despite vaccination in a patient treated by infliximab: a case report. BMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02397-5
|
5 |
Bo Feng, Jia-Rui Zheng. Importance of quantitative HBsAg detection in whole course management of patients with chronic hepatitis B. World Chinese Journal of Digestology 2022; 30(15): 655 doi: 10.11569/wcjd.v30.i15.655
|